A news story recently in the New York Times
has unveiled a growing concern among pediatric oncologists and health
care institutions at large. The injectable form of preservative free
methotrexate, commonly used to treat pediatric patients with leukemia and osteosarcoma, is in short supply.
The bigger drug shortage picture
Drug shortages are an increasingly frequent and serious problem affecting health care organizations across the country.
